Alliancebernstein L.P. Catalyst Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 120,042 shares of CPRX stock, worth $2.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

120,042

Previous 125,742 4.53%

Holding current value

$2.47 Million

Previous $1.95 Million 22.55%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.19 - $21.35 $86,583 - $121,695	-5,700 Reduced 4.53%	120,042 $2.39 Million
Q2 2024 Aug 14, 2024	BUY	$14.68 - $16.92 $126,101 - $145,342	8,590 Added 7.33%	125,742 $1.95 Million
Q4 2023 Feb 14, 2024	BUY	$11.78 - $17.29 $48,298 - $70,889	4,100 Added 3.63%	117,152 $1.97 Million
Q3 2023 Nov 14, 2023	SELL	$11.69 - $15.02 $2.17 Million - $2.79 Million	-186,030 Reduced 62.2%	113,052 $1.32 Million
Q2 2023 Aug 15, 2023	BUY	$11.5 - $18.08 $1.87 Million - $2.94 Million	162,460 Added 118.91%	299,082 $4.02 Million
Q1 2023 May 15, 2023	SELL	$14.34 - $21.05 $202,638 - $297,457	-14,131 Reduced 9.37%	136,622 $2.27 Million
Q4 2022 Feb 14, 2023	SELL	$12.25 - $19.5 $48,338 - $76,947	-3,946 Reduced 2.55%	150,753 $2.8 Million
Q3 2022 Nov 15, 2022	SELL	$7.06 - $15.52 $2.56 Million - $5.63 Million	-363,012 Reduced 70.12%	154,699 $1.99 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $8.57 $2.39 Million - $3.28 Million	383,311 Added 285.2%	517,711 $3.63 Million
Q1 2022 May 13, 2022	BUY	$5.31 - $8.31 $2,655 - $4,155	500 Added 0.37%	134,400 $1.11 Million
Q3 2021 Nov 10, 2021	SELL	$4.85 - $6.04 $39,032 - $48,609	-8,048 Reduced 5.67%	133,900 $710,000
Q1 2021 May 06, 2021	SELL	$3.45 - $4.69 $51,194 - $69,594	-14,839 Reduced 9.46%	141,948 $654,000
Q4 2020 Feb 08, 2021	BUY	$2.97 - $3.83 $23,721 - $30,590	7,987 Added 5.37%	156,787 $524,000
Q2 2019 Aug 14, 2019	BUY	$2.7 - $6.11 $161,190 - $364,767	59,700 Added 67.0%	148,800 $571,000
Q1 2019 May 14, 2019	BUY	$2.11 - $5.33 $89,886 - $227,058	42,600 Added 91.61%	89,100 $454,000
Q4 2018 Feb 13, 2019	BUY	$1.92 - $3.62 $19,392 - $36,562	10,100 Added 27.75%	46,500 $89,000
Q3 2018 Nov 08, 2018	BUY	$2.81 - $3.78 $20,232 - $27,216	7,200 Added 24.66%	36,400 $138,000
Q2 2018 Aug 13, 2018	BUY	$2.26 - $3.84 $25,989 - $44,160	11,500 Added 64.97%	29,200 $91,000
Q1 2018 May 14, 2018	BUY	$2.39 - $4.01 $17,447 - $29,273	7,300 Added 70.19%	17,700 $42,000
Q4 2017 Feb 13, 2018	SELL	$2.51 - $4.4 $3,513 - $6,160	-1,400 Reduced 11.86%	10,400 $41,000
Q3 2017 Nov 13, 2017	BUY	$2.4 - $2.94 $28,320 - $34,692	11,800	11,800 $30,000

Others Institutions Holding CPRX

# of Institutions

326

Shares Held

94.6M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Catalyst Pharmaceuticals, Inc. Transaction History